Our Governance

What is our vision?

To improve outcomes for people with osteoarthritis and low back pain and reduce the economic burden of these musculoskeletal conditions.




What is our mission?

To be a source of high quality research that informs the translation of evidence into practice for the management of osteoarthritis and low back pain.

Why does it matter?

CRE musculoskeletal research

Musculoskeletal disorders are a National Health Priority and one of the most expensive disease groups in Australia. The recent Global Burden of Diseases highlighted that the burden of death and disability from musculoskeletal disorders in Australia is second only to that from cancer.  Osteoarthritis and low back pain are two of the biggest musculoskeletal contributors to this burden and affect nearly 2 and 3 million Australians respectively with projected increases of 58% and 31% by 2032. Total costs are estimated at $3.75 billion per annum for low back pain and $4.79 billion for osteoarthritis.

Why do we exist?

There is high quality evidence that care for people with osteoarthritis and low back pain is suboptimal in Australia and internationally. Gaps in care can be loosely divided into clinician- and patient-related gaps. The National Health and Medical Research Council (NHMRC) Centre of Research Excellence (CRE) in Translational Research in Musculoskeletal Pain will conduct implementation research to address these evidence-practice gaps.

What will we do?

This CRE will conduct implementation research into the effectiveness of innovative models of care for OA and LBP to address the evidence-practice gaps. It will provide a coordinated multidisciplinary research approach to the problem, a more structured framework around which training and mentoring in implementation research can occur and for researchers and stakeholders to collaborate, as well as a platform to leverage additional funds and resources.



NHMRC CRE musculoskeletal research